Long-term efficacy and safety of low-dose rituximab in immune thrombocytopenia: a multicentre, prospective, open-label, randomised controlled trial
低剂量利妥昔单抗治疗免疫性血小板减少症的长期疗效和安全性：一项多中心、前瞻性、开放标签、随机对照试验
期刊:Annals of Hematology
影响因子:2.4
doi:10.1007/s00277-026-06908-2
Chen, Yunfei; Liu, Jiaying; Dai, Jiawen; Sun, Ting; Qiao, Zijian; Wang, Maosheng; Zhou, Hu; Zhou, Zeping; Liu, Xiaofan; Fu, Rongfeng; Xue, Feng; Liu, Wei; Ju, Mankai; Dong, Huan; Dai, Xinyue; Gu, Wenjing; Yang, Renchi; Zhang, Lei
